Literature DB >> 22715333

Functional role of neural injury in obstructive sleep apnea.

Julian P Saboisky1, Jane E Butler, Simon C Gandevia, Danny J Eckert.   

Abstract

The causes of obstructive sleep apnea (OSA) are multifactorial. Neural injury affecting the upper airway muscles due to repetitive exposure to intermittent hypoxia and/or mechanical strain resulting from snoring and recurrent upper airway closure have been proposed to contribute to OSA disease progression. Multiple studies have demonstrated altered sensory and motor function in patients with OSA using a variety of neurophysiological and histological approaches. However, the extent to which the alterations contribute to impairments in upper airway muscle function, and thus OSA disease progression, remains uncertain. This brief review, primarily focused on data in humans, summarizes: (1) the evidence for upper airway sensorimotor injury in OSA and (2) current understanding of how these changes affect upper airway function and their potential to change OSA progression. Some unresolved questions including possible treatment targets are noted.

Entities:  

Keywords:  myopathy; neuropathy; sleep apnea; upper airway muscles; upper airway physiology; upper airway reflexes

Year:  2012        PMID: 22715333      PMCID: PMC3375463          DOI: 10.3389/fneur.2012.00095

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


Introduction

In the upper airway there are changes in sensation, muscle properties, and neural drive in patients with obstructive sleep apnea (OSA). These changes are loosely termed airway remodeling and may adversely affect upper airway function during sleep. Changes in nerve and muscle properties may result from vibration through snoring, hypoxia, or both. The extent to which snoring and hypoxia exacerbate the disease and lead to important damage is unresolved. In this review, some of the more convincing evidence for and against upper airway remodeling in which data have been acquired in both OSA patients and non-OSA controls is highlighted. We review the pathophysiological evidence under three separate headings: (1) anatomical remodeling of the upper airway muscles, (2) efferent changes, and (3) afferent changes (see Figure 1). This encompasses evidence from a variety of neurophysiological approaches including histological, electrophysiological, and physiological studies. The function of upper airway reflexes and tongue force/fatigue characteristics in OSA vs. non-OSA subjects is also briefly reviewed. Finally, we discuss how upper airway remodeling and neural injury might contribute to upper airway closure during sleep.
Figure 1

Types of evidence for neuromuscular pathology in OSA. MUSCLE: Remodelling may be reflected via anatomical changes within the upper airway muscles (red); EFFERENT: changes in the electromyogram (EMG) of the upper airway muscles innervated via the cranial nerves (blue); AFFERENT: changes in sensory pathways (green). NCAM=neural cell adhesion molecule.

Types of evidence for neuromuscular pathology in OSA. MUSCLE: Remodelling may be reflected via anatomical changes within the upper airway muscles (red); EFFERENT: changes in the electromyogram (EMG) of the upper airway muscles innervated via the cranial nerves (blue); AFFERENT: changes in sensory pathways (green). NCAM=neural cell adhesion molecule.

Anatomical Structure of Upper Airway Muscles

Several histological studies support the presence of upper airway remodeling in patients with OSA (Tables 1 and 2). Broadly, this includes changes in: muscle fiber type, direction of muscle fibers, and anatomical arrangement of nerve fiber terminals. Sixteen studies are summarized in Table 2. Most of these studies did not rule out OSA in the healthy non-OSA/control groups (full polysomnography evaluations are reported in only four studies). Thus, the reported magnitude of these changes may be an underestimation. The upper airway muscles are composed of a variety of fast and slow muscle fiber types (Table 1) with conventional myosin heavy chain (MHC) isoforms and three primary MHC phenotypes and two subtypes (in order of prevalence for the adult genioglossus muscle in non-OSA subjects MHCIIA > MHCI-IIX > MHCI > MHCI-IIA > MHCIIX; Daugherty et al., 2012). A limitation of biopsies is that they are obtained from a limited area and may not represent the characteristics of the whole muscle. Nonetheless, a number of studies have shown an increase in the percentage of Type IIA muscle fibers in the order of ∼15% in several upper airway muscles in OSA patients including the uvula, genioglossus, medium pharyngeal constrictor, and palatopharyngeus (see Table 1; Smirne et al., 1991; Ferini-Strambi et al., 1998; Carrera et al., 1999; Series et al., 2000; Lindman and Stal, 2002; c.f. Friberg et al., 1998a). Type IIA muscle fibers are fast twitch fibers that can use both aerobic and anaerobic metabolism. While the cause for this increase in fiber type remains unknown, the change is likely to reflect training. Repetitive loading with regular nightly eccentric contractions (neural drive advancing the tongue anteriorly with negative airway pressure pulling the tongue posteriorly) combined with hypoxia may lead to fiber type alterations in the upper airway muscles indicative of an endurance trained muscle (Hildebrand et al., 1991; Pette and Staron, 2001). However, studies to definitively isolate the effects of training on upper airway muscle fiber type have not been done.
Table 1

Percentage of Type I, Type IIA, and Type IIB muscle fibers in non-OSA and patients with OSA.

MuscleNon-OSA % of fibers
OSA % of fibers
Author
Type IType IIAType IIBType IType IIAType IIB
Genioglossus61394159Carrera et al. (1999)
33.348.818.33353.311.6Series et al. (1996)
Palatopharyngeus13.731.51.622.158.40.5Lindman and Stal (2002)
26771687De Vuono et al. (2007)
Medium pharyngeal constrictor4941.39.722.475.22.4Smirne et al. (1991)
51.936.111.830.761.87.5Ferini-Strambi et al. (1998)
Uvula15.269.210.110.782.64.3Series et al. (1995)
10.673.515.98.182.39.6Series et al. (1996)
∼1576.1∼1.889.4Series et al. (2000)
12.865.34.819.555.816.1Lindman and Stal (2002)

Histological biopsy studies have confirmed differences in the muscle properties between non-OSA subjects and patients with OSA. There is an increase in the fraction of Type IIA fiber types in human upper airway musculature. Note: Type IIB fibers in humans are now referred to as Type IIX. Note: some rows do not total 100%. In some cases the number of Type IIB fibers were too low to be considered for calculation (e.g., Series et al., .

Table 2

Anatomical structural changes.

ReferenceMain findingsComments
Woodson et al. (1991)Soft palate and uvula biopsy; histological differences in soft palate and uvula in OSA vs. snorers and non-snorers measured via electron microscopyNotes A and B
• Focal degeneration of myelinated nerve fibers and axons in OSA
• Focal muscle fiber atrophy in snorers and OSA
• Muscle bundle disruption and fiber degeneration in all snorers and OSA
Edstrom et al. (1992)Palatopharyngeal muscle biopsy; neurogenic changes in OSA vs. non-OSANote A
• ↑ Number of angulated atrophic fibers
• Fiber type grouping
• Muscle fiber atrophy
Series et al. (1995)Uvula biopsy; altered anatomy and function in OSA patients vs. snorersAll subjects had sleep studies
• ↑ Cross-sectional area and Type IIA muscle fiber area in OSANo healthy control group
• Creative kinase, GADPH, phosphofructokinase, and phosphorylase ↑ in OSA (all elements in the anaerobic pathway)Findings consistent with a muscle training effect
• ↑ Twitch and tetanic tension in OSA
• Fatigability index similar between the two groups
Series et al. (1996)Uvula and genioglossus biopsies; altered anatomy in OSA patients vs. snorersAll subjects had sleep studies
• Uvula ↑ glycolytic, glycogenolytic, and anaerobic enzyme activitiesNo healthy control group
• No difference in genioglossus glycolytic and anaerobic enzyme activitiesSnorers had a low AHI
• Uvula and genioglossus: ↑ Type IIA, ↓ Type IIB muscle fiber%, and no change in muscle fiber areaFindings consistent with a muscle training effect
Friberg et al. (1997)Soft palate mucosa biopsy; neurogenic changes in OSA vs. snorers and non-snorersNote A
• ↑ Density of afferent nerve endings in epitheliumNon-OSA = chronic tonsillitis and one pharyngeal tumor
• ↑ Number of varicose nerve endings in epithelium
• ↑ Nerves containing neuropeptides (↑ PGP9.5 density indicating increased neurons and nerve fibers)Epithelium thicker in OSA
Ferini-Strambi et al. (1998)Medium pharyngeal constrictor and quadricep biopsies; altered anatomy of pharyngeal constrictor, but, not quadricep muscle in OSA vs. non-OSAOSA based on clinical symptoms and portable monitor
• ↑ % Type I, ↑ % Type IIA, and ↓ % Type IIB
• ↑ Type IIA fiber diameter
Friberg et al. (1998a)Palatopharyngeal and anterior tibial biopsies; altered anatomy of palatopharyngeal, but, not in anterior tibial muscle in OSA vs. non-OSANote A, interviewed history, and spouses
• Similar palatopharyngeal muscle fiber type distributionNon-OSA = tonsillectomy chronic tonsillitis, 2 for tumor
• ↑ Palatopharyngeal muscle fiber size variations
• Rounded atrophic palatopharyngeal muscle fibers
• ↑ Incidence of centrally located nuclei and split palatopharyngeal muscle fibers
• Palatopharyngeal muscle fiber type grouping
Carrera et al. (1999)Genioglossus biopsy; altered anatomy and function in OSA vs. non-OSANote A
• Untreated OSA patients ↑ % Type II muscle fibers, and ↑ fatigabilityNo break down of muscle fibers into Type IIA and B
• No differences in muscle fiber distribution and fatigability in a separate analysis of CPAP treated patients vs. non-OSANot the same subjects pre- and post-treatment
Series et al. (2000)Uvula muscle biopsy; altered anatomy in OSA patients vs. snorersAll subjects had sleep studies
• ↑ % Type IIA muscle fibersNo control group
• No difference in muscle fiber area in Type I or II, thus, no evidence for atrophy or hypertrophy
Paulsen et al. (2002)Uvula mucosa biopsy; altered anatomy in OSA patients vs. snorers and non-OSA. Measured via electron microscopyNote B
• Absence of connective tissue papillae
• ↓ Cytokeratins
• Acanthosis of epithelium
• ↑ Leukocytes inside the lamina propria
Lindman and Stal (2002)Uvula and palatopharyngeus biopsies; altered anatomy in OSA patients vs. non-OSANote B
• ↓ Ratio of area of palatopharyngeus muscle fibers to connective tissue in OSA patients
• ↑ Palatopharyngeus muscle Type I, ↑ Type IIA, and ↓ Type IIAB and IIB muscle fibers in OSA patients
• ↓ Uvula muscle fiber diameters for all fiber types except Type IIC/IM
Boyd et al. (2004)Soft palate and/or tonsillar pillar biopsies; denervation in OSA patients vs. non-OSANote A, screened via questionnaire
• ↑ PGP9.5 specifically expressed in the neurons and nerve fibers
• ↑ Sarcolemmal expression of N-CAM 16 vs. 1%
De Vuono et al. (2007)Palatopharyngeal biopsy; similar findings in children with OSA, vs. snorers vs. controls with the presence of each of the following in similar proportionsAll subjects had sleep studies Findings suggest that these histological features may reflect a “normal” muscle rather than neurogenic or myopathic pathology
• Muscle fiber size variability
• Rounded atrophic muscle fibers
• ↑ Type II muscle fibers
• Irregular muscle fiber architecture “moth-eaten”
Stål et al. (2009)Uvula and palatopharyngeaus biopsies; altered anatomy in OSA patients vs. non-OSANote A, no history of any significant disease Note B
• ↓ Capillary density per muscle fiber area
• Histopathological in all OSA muscle biopsies: fibrosis, variability in fiber size, developmental MyHC isoforms
Bassiouny et al. (2009)Uvula biopsies; degenerative anatomical changes to both myelinated and unmyelinated nerve endings in OSA patients vs. snorers and non-OSANote A, confirmed via partners and medical history
• Myelin sheath had obvious signs of: degenerated and irregular Schwann cells, lamellated bodies, neurofilament loss, and fatty degenerationNote B
Non-OSA died from causes unrelated to head and neck
Stål and Johansson (2012)Uvula and palatopharyngeaus biopsies; altered anatomy in OSA patients vs. non-OSANote A, previously physically healthy Note B
• ↓ Capillaries around abnormal muscle fibers
• Abnormal mitochondrial distribution
• Uvula ↑ fiber hypertrophy
• Palatopharyngeus muscle fibers display signs of both atrophy and hypertrophy in OSA vs. controls

Note A: indicates that overnight sleep studies were not performed in the non-OSA group.

Note B: indicates that samples from the non-OSA group were obtained via autopsy.

Percentage of Type I, Type IIA, and Type IIB muscle fibers in non-OSA and patients with OSA. Histological biopsy studies have confirmed differences in the muscle properties between non-OSA subjects and patients with OSA. There is an increase in the fraction of Type IIA fiber types in human upper airway musculature. Note: Type IIB fibers in humans are now referred to as Type IIX. Note: some rows do not total 100%. In some cases the number of Type IIB fibers were too low to be considered for calculation (e.g., Series et al., . Anatomical structural changes. Note A: indicates that overnight sleep studies were not performed in the non-OSA group. Note B: indicates that samples from the non-OSA group were obtained via autopsy. Anatomical changes consistent with upper airway muscle remodeling in OSA in adults include: increased prevalence of angulated muscle fibers, increased diameter of muscle fibers (Smirne et al., 1991; Ferini-Strambi et al., 1998; Series et al., 2000; Sauleda et al., 2003; Svanborg, 2005; De Vuono et al., 2007; Stål et al., 2009), atrophied muscles fibers (Edstrom et al., 1992; Friberg et al., 1998a), changes in capillary density and mitochondria content (Stål et al., 2009; Stål and Johansson, 2012), fiber type grouping (Edstrom et al., 1992; Ferini-Strambi et al., 1998; see Table 2), and increased neural cell adhesion molecule (N-CAM) expression (Boyd et al., 2004). However, one study found similarly widespread neurogenic changes in children both with and without OSA (De Vuono et al., 2007). Thus, questions remain as to what degree of chronic partial denervation is “normal” for upper airway muscles. Snoring is a key feature of OSA. The vibration induced by snoring and the mechanical strain caused by repetitive upper airway closure is associated with inflammatory changes to soft tissue structures of the upper airway (Berger et al., 2002; Boyd et al., 2004). The local inflammation increases the thickness of the surrounding tissues and may narrow the upper airway to exacerbate obstructive apneas (Rubinstein, 1995; Sekosan et al., 1996; Berger et al., 2002). Patients with severe snoring have soft palate swelling in the morning that recedes while awake (Sekosan et al., 1996). There is also increased fat in and around the muscles of the upper airway in patients with OSA (Horner et al., 1989; Stauffer et al., 1989; Schwartz et al., 1991; Zohar et al., 1998b; Berger et al., 2002). The importance of increased fat is highlighted by the observation that weight loss in obese OSA patients can eliminate airway obstruction. While infiltration of fat is not a result of neural changes, it will alter the dynamics of the upper airway. With increased intramuscular fat, contractile performance may change via altered loading of individual muscle fibers and altered “passive” properties (Busha et al., 2002). Given that some of the tension developed in one part of the muscle can be transmitted via shear links to other parts of the muscle (Kjaer, 2004), increased fat may alter the force distribution across muscle fibers in OSA patients. Nevertheless, maximal voluntary tongue protrusion force is the same, or increased in OSA patients (e.g., Mezzanotte et al., 1992; Mortimore et al., 2000; Eckert et al., 2011).

Evidence for Upper Airway Efferent Changes

In addition to changes in the soft tissues and muscle fibers, there are also electrophysiological changes in the muscles of patients with OSA (Table 3). During wakefulness patients with OSA have higher levels of multiunit electromyographic activity (EMG) recorded in the upper airway muscles compared to healthy control subjects (Mezzanotte et al., 1992, 1996; Fogel et al., 2001; c.f. Series et al., 2009). The apparent increase in drive was ascribed to a neural compensation for a narrow upper airway. This concept became widely accepted. The neural compensation was thought to be analogous to that in diaphragm and other obligatory inspiratory muscles of patients with chronic obstructive pulmonary disease where more motor units are recruited and their average discharge frequencies are higher (De Troyer et al., 1997; Gorman et al., 2005) because of the increased resistive load. Recent studies indicate that motor unit discharge frequencies also increase with higher neural drive to the genioglossus (Bailey et al., 2007; Saboisky et al., 2010). However, there is currently no strong evidence to support an overall increase in the discharge frequencies, or recruitment of additional motor units in the genioglossus in OSA during wakefulness (Saboisky et al., 2007, 2012). During the pre-inspiratory phase of the respiratory cycle the overall excitability of the genioglossus motoneuron pool appears to be increased in OSA patients vs. controls. The timing of the initial activation of phasic inspiratory motor units is earlier (Saboisky et al., 2007). Similarly, during late expiration, the conduction times of motor evoked potentials elicited via transcranial magnetic stimulation of the motor cortex are shorter in the genioglossus in OSA patients than in controls (Wang et al., 2010). Thus, while there is currently no evidence for increased discharge frequencies or additional recruitment of motor units there are quantifiable changes in the timing of neural drive to genioglossus in OSA. Therefore, how do the new findings fit with these earlier studies?
Table 3

Efferent changes.

ReferenceMain findingsComments
Mezzanotte et al. (1992)Fine-wire intramuscular multiunit genioglossus electromyography; increased neural drive in OSA vs. non-OSANote A
• ↑ Peak EMG during quiet breathing
Fogel et al. (2001)Fine-wire intramuscular genioglossus electromyography; increased neural drive in OSA vs. non-OSANote A
• ↑ EMG during wakefulness (↑ tonic activation and ↑ negative-epiglottic pressure during entrained iron-lung ventilation in inspiration)Primary analysis included older OSA patients
• No difference in mean EMG/Pepi relationship in OSA and controls under all conditions (basal breathing, iron-lung ventilation and heliox breathing)Not matched for BMI
• Age matched sub-analysis EMG not increased (but trended ↑ in OSA tonic, peak, and phasic)
Svanborg (2005)Concentric needle single motor unit palatopharyngeus electromyography; neurogenic changes in OSA patients vs. snorers and controlsNote A
• 10/12 OSA evidence of lesions: polyphasic potentials, 3/15 snorers exhibited “moderate” lesions
Saboisky et al. (2007)Monopolar needle single motor unit genioglossus electromyography; neurogenic changes in OSA patients vs. controlsNote B Not matched for BMI
• ↑ Area and longer duration action potentials
• Distribution of six unit types identical between groups
• Inspiratory units recruited earlier in OSA patients
• ↑ Peak discharge frequencies of Inspiratory Phasic units but, inspiratory tonic ↓ in OSA
Series et al. (2009)Transcrainal magnetic stimulation and surface genioglossus and diaphragm electromyography; different responses in OSA patients vs. controlsNote B
• ↓ Latency of genioglossus MEPs during tongue protraction
• Negative correlation between genioglossus MEP latency and AHI
• Similar baseline genioglossus EMG activity in OSA patients and controls during quiet breathing
Ramchandren et al. (2010)Hypoglossal nerve conduction; abnormalities in patients with OSA vs. controlsNote A
• ↓ Compound muscle action potential amplitudesTreated OSA subjects
Saboisky et al. (2012)Concentric needle MACRO and single motor unit genioglossus electromyography; neurogenic changes in OSA patients vs. controlsNote B Large sample: no timing data minimal frequency data No snoring data BMI matched subjects
• ↑ Duration, size index, relative irregularity coefficient, phases, turns, area to amplitude ratio area/phase, and MACRO duration amplitude and area
• No difference in peak to peak amplitudes
• Irregularity coefficient correlated with minimal overnight oxygen saturation

Note A: indicates that overnight sleep studies were not performed in the non-OSA group.

Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.

Efferent changes. Note A: indicates that overnight sleep studies were not performed in the non-OSA group. Note B: indicates that both the OSA and non-OSA group had overnight sleep studies. An alternative explanation is that the elevated EMG in the upper airway muscles in patients with OSA is secondary to neurogenic remodeling. This is characterized as chronic partial denervation of muscle fibers, with reinnervation of the orphaned muscle fibers by collateral sprouting of surviving motor axons (Boyd et al., 2004; Gonzalez-Forero et al., 2004). The overall duration of motor unit potentials increase, often with increased amplitude (Bertorini et al., 1994; Preston and Shapiro, 2002). Recent investigations using single motor unit techniques have shown that the motor unit potentials of upper airway muscles in OSA patients are larger in area, longer in duration, and more complex (Svanborg, 2005; Saboisky et al., 2007, 2012; see also Podnar and Dolenc Groselj, 2010). These changes could contribute to the increased multiunit EMG in OSA. Thus, active remodeling may help to preserve the functional capacity of the muscles. However, the presence of denervation and subsequent axonal sprouting may lead to changes in fine motor control such as speech (Goldshtein et al., 2011). An additional potential problem with the initial reports of increased multiunit EMG in OSA (awake) is that values were normalized to the EMG produced during a maximal volitional task and may not be comparable between OSA patients and controls.

Evidence for Upper Airway Afferent Changes

If the anatomically deeper upper airway motor axons are affected by vibration, sensory afferents, closer to the airway surface, should also be impaired. However, the evidence supporting sensory nerve impairment in OSA is less convincing than that for motor nerves. If sensory nerves are affected, this may impair normal reflex mechanisms which contribute to upper airway function. A variety of techniques have revealed potential sensory impairments in OSA. Two-point discrimination and detection of vibration, airflow, and temperature for the upper airway are all altered in OSA patients (see Table 4). The ability to detect and rate the size of inspiratory resistive loads to breathing in patients with OSA is impaired (McNicholas et al., 1984; Tun et al., 2000; c.f. Clerk et al., 1994). However, cognitive processing is important for these measurements and they may be independently affected by sleepiness and prior respiratory loading. Airway edema is present in untreated OSA patients and may impair upper airway sensation. Thus, separating the relative contribution of airway edema and sleepiness and cognitive processing vs. sensory nerve injury is difficult. One strategy to overcome some of these confounders is to repeat measurements after an acute period of continuous positive airway pressure (CPAP) treatment. Here, edema and sleepiness are likely to resolve more rapidly than potential nerve injury changes. In support of a role of long-term sensory injury in OSA, one study revealed only partial resolution of oropharynx sensation with vibration detection and two-point discrimination after 4 months of CPAP therapy (Kimoff et al., 2001). However, in another study, impaired sensation to loaded breathing was corrected after 2 weeks of CPAP therapy (Tun et al., 2000). In untreated OSA patients breathing responses to respiratory stimuli measured during wakefulness vary. Impaired respiratory load detection is associated with a reduction in the ventilatory response to hypercapnia (McNicholas et al., 1984). Conversely, the ability to adjust breathing (e.g., respiratory timing and minute ventilation) in response to respiratory loading may be unaltered in OSA (Hlavac et al., 2007).
Table 4

Afferent changes.

ReferenceMain findingsComments
McNicholas et al. (1984)Inspiratory resistive load detection thresholds; decreased ability to detect inspiratory resistive loads in OSA patients vs. non-OSANote C
Clerk et al. (1994)Inspiratory resistive loads detection thresholds; not different in normal weight OSA patients vs. non-OSANote C
Friberg et al. (1998b)Soft palate mucosa Laser Doppler perfusion/electrical stimulation; altered afferent nerve regulation in OSA Patients vs. snores and non-OSANote A
• ↓ Vasodilatation of the peripheral mucosa of severe OSA patients vs. non-OSA
Tun et al. (2000)Inspiratory resistive load magnitude perception; reduced in untreated OSA vs. non-OSANotes A and C
• Reversed after 2 weeks CPAP therapy
Kimoff et al. (2001)Two-point discrimination and vibration sensation in the oropharynx, lip, and hand; reduced oropharynx, but, not lip and hand sensation in OSA and non-apneic snorers vs. controlsNote B and C Not matched for BMI
• Partial reversibility of changes post-CPAP in OSA, but, still impaired
• Anesthesia abolished two point discrimination in all patients and ↓ vibratory sensation
• Similar impairment in both snorers and OSA
Guilleminault et al. (2002)Two-point palatal discrimination; reduced in OSA vs. UARS and controlsNotes B and C
Gora et al. (2002)Respiratory-related evoked potentials (RREP); no difference in P1 amplitude or latency in OSA vs. non-OSANote A
Akay et al. (2003)Respiratory-related evoked potentials; reductions in early RREP activity in OSA vs. non-OSANote A
Predominantly CPAP treated OSA patients
Afifi et al. (2003)Respiratory and auditory evoked potentials; no difference in early waveform components in OSA vs. non-OSANote B, RDI defined using portable monitor
Nguyen et al. (2005)Sensory detection thresholds for air-pressure pulses delivered to the oropharynx, velopharynx, hypopharynx, and larynx determined via endoscope; specific alternations in certain OSA patients vs. controlsNotes B and C Reproducible measures after 3 months
• Two subgroups of patients with and without abnormal sensory measures at multiple upper airway sites
• Correlations between laryngeal sensory measures and apnea severity and nadir SaO2
Dematteis et al. (2005)Sensory perception thresholds at the soft palate to varying airflow rates; reduced sensitivity in OSA patients vs. controlsNotes B and C OSA patients untreated
• Pharyngeal sensitivity correlated with OSA severity
Hlavac et al. (2007)Inspiratory resistive load magnitude perception; reduced in untreated OSA vs. controlsNotes B and C
Donzel-Raynaud et al. (2009)Respiratory-related evoked potentials; no difference in P1 amplitude or latency in OSA vs. controlsNote B
Eckert et al., 2011Respiratory-related evoked potentials and genioglossus and tensor palatini electromyography; no difference in early P1 component and reflex onset latency to brief negative upper airway pressure pulses in untreated OSA patients vs. controlsNote B
Sunnergren et al. (2011)Soft palate and lip temperature detection thresholds; impaired in OSA patients vs. controlsNotes B and C
• Soft palate thresholds: 6.6°C OSA, 5.1°C Snorers, 2.8°C non-snorers
Grippo et al. (2011)Respiratory-related evoked potentials; reductions in early RREP activity in OSA vs. controlsNote B
OSA patients untreated

Note A: indicates that overnight sleep studies were not performed in the non-OSA group.

Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.

Note C: indicates that finding may not represent primary sensory impairment; potentially influenced by confounders such as impairments in cognitive processing or edema related to OSA.

Afferent changes. Note A: indicates that overnight sleep studies were not performed in the non-OSA group. Note B: indicates that both the OSA and non-OSA group had overnight sleep studies. Note C: indicates that finding may not represent primary sensory impairment; potentially influenced by confounders such as impairments in cognitive processing or edema related to OSA. Cortical evoked potentials can provide information about peripheral and central transmission as well as cortical processing of sensory information. Delays in the timing and/or reductions in amplitude of the early components of evoked potentials may reflect afferent impairment. The early parameters do not require a perceptual decision and are less affected by sleepiness. Measured during wakefulness, brainstem auditory evoked responses do not appear to be abnormal in OSA (e.g., Mosko et al., 1981; Karnaze et al., 1984). Similarly, the latency and amplitude of the early N1 component of the cortical evoked response to auditory stimuli are not altered in OSA patients (Afifi et al., 2003; Vakulin et al., 2012). Of relevance to the upper airway, several studies have examined respiratory-related evoked potentials (RREPs) during wakefulness in OSA. Consistent with impaired sensory transmission to respiratory stimuli, two studies revealed a reduction in the amplitude but not the latency of the early RREP components to brief negative pressures during inspiration (Akay et al., 2003) and expiration (Grippo et al., 2011). However, other studies have shown no difference in P1 amplitude or latency (reflecting the arrival of the sensory information to the cortex) of the RREP to inspiratory occlusions and negative pressures in OSA patients (Gora et al., 2002; Afifi et al., 2003; Donzel-Raynaud et al., 2009; Eckert et al., 2011). During sleep, P1 does not appear to be different between OSA patients and controls (Gora et al., 2002; Afifi et al., 2003). However, the amplitude of the latter N550 component (reflecting sensory processing) is reduced in the OSA patients (Gora et al., 2002; Afifi et al., 2003). While recordings of peripheral sensory and motor nerve potentials are affected by obesity, several findings consistent with sensory neuropathy have been observed in nerves innervating limb muscles and organs in patients with OSA (Mayer et al., 1999; Fanfulla et al., 2000; Lüdemann et al., 2001; Dziewas et al., 2007). OSA patients show evidence of a mild axonal neuropathy in the sural, median, and ulnar nerves (Mayer et al., 1999; Dematteis et al., 2001; Lüdemann et al., 2001; Dziewas et al., 2007). Two studies report slower sensory conduction and smaller amplitude responses (Mayer et al., 1999; Fanfulla et al., 2000). In addition, it is notable that comparable changes have been observed for the compound muscle action potential in the median, sural, and ulnar nerves (Mayer et al., 1999; Lüdemann et al., 2001; Dziewas et al., 2007). This finding occurs when controlling for the increased body mass index in OSA (Dziewas et al., 2007). Thus, intermittent hypoxia may mediate systemic neural changes in OSA that are not isolated to the upper airway. In summary, these findings reveal varying levels of sensory impairment to certain sensory stimuli in OSA. While the precise pathophysiological role of sensory impairment remains uncertain, sensory testing using calibrated airflow has been proposed as a screening test for OSA (Dematteis et al., 2005). There may also be different populations of OSA patients; those with sensory impairments and those patients without (Nguyen et al., 2005). Thus, while sensory impairments may play a key role to obstructions in some patients with OSA, neuromuscular, and anatomical influences may be more important in others.

Function

Upper airway reflexes

The integrity of the swallowing reflex is impaired in OSA patients and snorers compared to controls (Table 5). A greater bolus volume is required to elicit the swallowing reflex, swallowing onset latency is delayed, and bolus leakage throughout the pharynx occurs more frequently in OSA patients and snorers compared to controls (Zohar et al., 1998a; Teramoto et al., 1999; Jäghagen et al., 2000; Levring Jaghagen et al., 2003; Valbuza et al., 2011b). Inhibition of inspiration associated with swallowing is also less pronounced in OSA (Teramoto et al., 1999). While these changes would favor aspiration laryngeal penetration was uncommon. This indicates that alterations in swallowing are predominantly subclinical in OSA. CPAP may improve subclinical swallowing dysfunction in OSA (Okada et al., 2000). Palatal reflexes to tactile stimuli such as the gag reflex are diminished, particularly in severe OSA (Valbuza et al., 2011a). The extent to which these changes are caused by sensory impairments or efferent changes and whether or not they influence OSA severity remains unknown.
Table 5

Functional changes.

ReferenceMain findingsComments
UPPER AIRWAY REFLEXES
Mortimore and Douglas (1997)Fine-wire intramuscular multiunit levator palatini and palatoglossus electromyography; reduced EMG responses to negative upper airway pressure pulses in OSA patients vs. non-OSANote A Large MTA (100 ms) not appropriate for examining reflexes
• CPAP treated patients had similar EMG responses vs. non-OSA
EMG latencies unknown
Zohar et al. (1998a)Swallowing provocation test and scintigraphy testing; altered swallowing reflex in OSAMinimal sleep monitoring (sound and O2) in non-OSA
• Impaired bolus clearance in the oral cavity
• Surgery (UPPP) improved bolus clearance but was not related to reductions in RDI
Teramoto et al. (1999)Swallowing provocation test; altered swallowing reflex in OSA vs. age, gender, and BMI matched controlsNote B
• ↓ Onset latency
• ↓ Inspiratory suppression time from the termination of swallowing to the next onset of inspiration
• ↑ Provocant required to elicit swallow reflex
Jäghagen et al. (2000)Swallowing provocation and videoradiographic testing; altered swallowing function in OSA patients and snorers vs. non-OSANote A
• Impaired swallowing function in 54 vs. 7% in the controls
• No correlation between swallowing function and severity of snoring
Levring Jaghagen et al. (2003)Swallowing provocation and videoradiographic testing; altered swallowing function in OSA patients and snorers vs. controlsNote A
• Dysfunction in 50% with AHI of >30, 61% AHI of 5–29, and 43% with AHI of <5 events/h
Berry et al. (2003)Multiunit surface and intramuscular genioglossus electromyography; slightly increased amplitude of EMG response to brief negative pressure pulses of moderate but not large magnitudeNote AOSA treated
MTA not appropriate for examining reflexes per se
Eckert et al. (2011)Fine-wire intramuscular multiunit genioglossus and tensor palatini electromyography; similar EMG responses in OSA patients vs. controlsNote B Not matched for BMI
• No difference in short latency reflex timing or amplitude to negative pressure pulses
• Peak genioglossus EMG and epiglottic pressure not different during passive iron-lung ventilation
Valbuza et al. (2011b)Swallowing provocation and nasal fibroscopy; Swallowing dysfunction in OSA vs. controlsNote B
• 64% had premature oral leakage to a food/liquid bolus
Valbuza et al. (2011a)Palatal and gag reflexes; absence of reflexes in moderate and severe OSA patients vs. controlsNote BPressure not standardized
VOLUNTARY TONGUE PROTRUSION FORCE/FATIGABLITY
Mezzanotte et al. (1992)Maximal tongue protrusion force; not different in four very severe OSA patients vs. four non-OSA (30 vs. 38 N)Note ALikely underpowered
Mortimore et al. (2000)Tongue protrusion tasks; similar in OSA vs. non-OSANote A
• No difference in maximal protrusion strengthMax tongue force only explained ∼4% of the variance in AHI
• No difference in tongue fatigability measured as time to hold a 50% of maximal contraction
• No change over the course of a night (AM vs. PM) in strength or fatigability
• ↓ Tongue strength with ↑ age, ↑ BMI, ↑AHI, and ↑neck size
Busha et al. (2002)Tongue protrusion tasks; similar in OSA vs. non-OSANote A
• Optimum length of the genioglossus longer in OSA patients vs. non-OSA
• At longer muscle lengths ↑ maximal protrusion force in OSA patients
• Endurance times similar between the two groups
Blumen et al. (2004)Tongue protrusion tasks; recovery longer in OSA vs. controlsNote B
• No change in endurance time or fatigability in OSA patients
• ↑ Time to recovery of initial maximal force in the OSA patients
• Final EMG median frequency was significantly higher and the final low-frequency EMG component smaller in the OSA patients
• Mean endurance time in the OSA patients 75% shorter
Shepherd et al. (2006)Maximal tongue protrusion force; increased in severe OSA (AHI 49 h) vs. mild/non-OSA (AHI 8 h) supine but not seatedNote B
• Tongue strength not related to AHI
Eckert et al. (2011)Tongue protrusion tasks; altered voluntary tongue protrusion force and fatigability in OSA patients vs. controlsNote B
• ↑ Maximal protrusion force
• ↓ Time to task failure (70% maximal force 5 s on 5 s off)

Note A: indicates that overnight sleep studies were not performed in the non-OSA group.

Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.

Functional changes. Note A: indicates that overnight sleep studies were not performed in the non-OSA group. Note B: indicates that both the OSA and non-OSA group had overnight sleep studies. Conversely, the upper airway negative pressure reflex, crucial for maintaining airway patency, does not appear to be impaired in OSA patients during wakefulness. Studies that were not optimally designed to measure reflex responses have shown reduced EMG activation in the palatal muscles (Mortimore and Douglas, 1997), comparable genioglossus EMG activation to high levels of negative pressure (−20 cm H2O), and elevated genioglossus EMG activity to moderate suction pressures (−10 to −13 cm H2O; Berry et al., 2003). However, a recent study using sensitive neurophysiological techniques found no differences in the timing or the amplitude of the genioglossus and tensor palatini negative pressure reflex during wakefulness between OSA patients and controls (Eckert et al., 2011).

Tongue Protrusion Force and Fatigability

Maximum voluntary force of the tongue protuders is comparable (Mezzanotte et al., 1992; Mortimore et al., 2000; Busha et al., 2002; Blumen et al., 2004) or increased (Shepherd et al., 2006; Eckert et al., 2011) in OSA patients. While the maximal force generating capacity in the tongue protuders does not appear to be impaired in OSA, whether or not they are more vulnerable to fatigue remains uncertain. Fatigability, quantified as time to task failure during sustained isometric tongue protrusion tasks at 30, 50, and 80% of maximum, were not different between OSA patients and controls (Mortimore et al., 2000; Blumen et al., 2004). Conversely, time to task failure during an intermittent isometric tongue protrusion task (5 s on 5 s off at 70% maximal force) occurred approximately twice as quickly in OSA patients vs. controls (Eckert et al., 2011). Similarly, recovery of maximal force capacity following submaximal isometric tongue protrusion tasks was prolonged in OSA patients (Blumen et al., 2004). How various voluntary tongue protrusion measures during wakefulness relate to upper airway patency during sleep and OSA severity remains unclear. In an earlier study, maximal tongue protrusion force positively correlated with OSA severity, albeit it only weakly (r2 = 0.04), whereas fatigability to a submaximal isometric sustained task did not (Mortimore et al., 2000). In a subsequent study, there was no correlation between maximal tongue protrusion force and OSA severity (Shepherd et al., 2006).

Summary and Potential Role of Neural Injury in OSA

Remodeling of the upper airway muscles occurs in OSA. The most commonly reported finding is an increase in the proportion of Type IIA muscle fibers, a change which is consistent with muscle training. Changes in multiunit EMG are difficult to interpret. Recent single motor unit studies reveal chronic partial denervation in OSA. Upper airway sensory impairments to a range of stimuli also occur in OSA. However, it remains challenging to differentiate the relative contribution of afferent neural injury vs. the confounding influences of OSA (e.g., edema) to primary impairments in sensation. Given that long-term vibration causes neurogenic changes in limb muscles (Takeuchi et al., 1986; Dahlin and Lundborg, 2001), snoring and its mechanical effects are likely to contribute to the observed upper airway anatomical, efferent, and afferent changes. However, intermittent hypoxia may also impair peripheral nerves in OSA. Thus, there is the potential for synergistic effects to mediate upper airway remodeling in OSA. Some of the changes in muscle properties and sensory impairments resolve, at least in part, with CPAP treatment (e.g., Carrera et al., 1999; Mayer et al., 1999; Tun et al., 2000; Kimoff et al., 2001; Nguyen et al., 2005; Dziewas et al., 2007). The evidence for a link between upper airway remodeling and the integrity of upper airway reflexes is limited. The swallow and gag reflexes are impaired in patients with OSA. However, the existing data does not support a link between the presence of swallowing impairment and OSA severity (Jäghagen et al., 2000) and the potential for an impaired gag reflex to influence OSA severity is uncertain. Other subtle alterations, such as changes in speech, may also occur in OSA. Importantly, there is no strong evidence to suggest that key protective reflexes involved in maintaining upper airway patency are impaired in OSA. In addition, the ability of the tongue to generate volitional protrusion force is similar or enhanced in OSA. However, despite the consistent observation of increased Type IIA fibers in the upper airway muscles of OSA patients, which would be predicted to increase resistance to muscle fatigue, the upper airway muscles may be more prone to fatigue. However, the laboratory task used to measure performance does not exactly mimic the repetitive movements associated with intermittent obstructions in OSA. Given the current uncertainty as to the links between changes in sensorimotor function and the upper airway in OSA and sleep-disordered breathing, how novel therapeutic targets might modify these upper airway pathophysiological changes is unclear. Nonetheless, recent studies have demonstrated that novel exercise training techniques (e.g., didgeridoo playing and a battery of tasks designed by a speech pathologist) can reduce OSA severity (e.g., Puhan et al., 2006; Guimarães et al., 2009). Recent studies using implantable devices to electrically stimulate the genioglossus muscle during sleep have shown reductions in OSA severity (e.g., Eastwood et al., 2011; Oliven, 2011). However, consistent with the varying causes of OSA, treatment response varies between patients (Dotan et al., 2011; Eastwood et al., 2011). The upper airway muscles are stronger and have an increased proportion of Type IIA muscle fibers in OSA. These findings suggest that the upper airway muscles are highly trained by chronic overnight loading and/or hypoxia. Nonetheless, targeted exercise tasks performed during wakefulness may further enhance these changes and potentially lead to improved neuromechanical performance during sleep. The use of some of the measurement techniques outlined in this review to study the effects before and after training would help address some of this uncertainty and may provide novel therapeutic targets.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  90 in total

1.  Soft palate sensory neuropathy in the pathogenesis of obstructive sleep apnea.

Authors:  Ola Sunnergren; Anders Broström; Eva Svanborg
Journal:  Laryngoscope       Date:  2011-02       Impact factor: 3.325

2.  Skeletal muscle changes in patients with obstructive sleep apnoea syndrome.

Authors:  Jaume Sauleda; Francisco José García-Palmer; Salvador Tarraga; Andreu Maimó; Andreu Palou; Alvar G N Agustí
Journal:  Respir Med       Date:  2003-07       Impact factor: 3.415

3.  Needle electromyography. Fundamentals, normal and abnormal patterns.

Authors:  David C Preston; Barbara E Shapiro
Journal:  Neurol Clin       Date:  2002-05       Impact factor: 3.806

Review 4.  Treating obstructive sleep apnea with hypoglossal nerve stimulation.

Authors:  Arie Oliven
Journal:  Curr Opin Pulm Med       Date:  2011-11       Impact factor: 3.155

5.  Auditory evoked potentials remain abnormal after CPAP treatment in patients with severe obstructive sleep apnoea.

Authors:  Andrew Vakulin; Peter G Catcheside; Stuart D Baulk; Nick A Antic; Cameron J van den Heuvel; Siobhan Banks; R Doug McEvoy
Journal:  Clin Neurophysiol       Date:  2011-08-06       Impact factor: 3.708

6.  Hypoglossal nerve conduction findings in obstructive sleep apnea.

Authors:  Sindhu Ramchandren; Kirsten L Gruis; Ronald D Chervin; Lynda D Lisabeth; Maryann Concannon; James Wolfe; James W Albers; Devin L Brown
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

7.  Muscle fibre type and habitual snoring.

Authors:  S Smirne; S Iannaccone; L Ferini-Strambi; M Comola; E Colombo; R Nemni
Journal:  Lancet       Date:  1991-03-09       Impact factor: 79.321

8.  The length-force relationship of the human genioglossus in patients with obstructive sleep apnea.

Authors:  Brett F BuSha; Richard J Strobel; Sandra J England
Journal:  Respir Physiol Neurobiol       Date:  2002-04       Impact factor: 1.931

9.  Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement.

Authors:  F Fanfulla; S Malaguti; T Montagna; S Salvini; C Bruschi; P Crotti; R Casale; C Rampulla
Journal:  Sleep       Date:  2000-09-15       Impact factor: 5.849

10.  Blunted respiratory-related evoked potential in awake obstructive sleep apnoea subjects: a NEP technique study.

Authors:  Antonello Grippo; Riccardo Carrai; Isabella Romagnoli; Francesco Pinto; Francesco Fanfulla; Antonio Sanna
Journal:  Clin Neurophysiol       Date:  2011-02-08       Impact factor: 3.708

View more
  18 in total

Review 1.  Neurogenic changes in the upper airway of obstructive sleep apnoea.

Authors:  Julian P Saboisky; Jane E Butler; Billy L Luu; Simon C Gandevia
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

Review 2.  [Pathophysiology of obstructive sleep apnea].

Authors:  C Heiser; D Eckert
Journal:  HNO       Date:  2019-09       Impact factor: 1.284

3.  Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea.

Authors:  Anthony J Grady; Jane S Hankins; Brent Haberman; Robert Schoumacher; Rose Mary Stocks
Journal:  Sleep Breath       Date:  2017-01-11       Impact factor: 2.816

4.  Accelerated echo-planar J-resolved spectroscopic imaging in the human brain using compressed sensing: a pilot validation in obstructive sleep apnea.

Authors:  M K Sarma; R Nagarajan; P M Macey; R Kumar; J P Villablanca; J Furuyama; M A Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-06       Impact factor: 3.825

5.  Muscle type of palatopharyngeal muscle in children with severe obstructive sleep apnea.

Authors:  Huaihong Chen; Xiaoxing Huang; Yanqing Ye; Yunfang Luo; Yuanshou Huang; Xiangping Li
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

6.  Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.

Authors:  Maria Laura Ester Bianchi; Anna Losurdo; Chiara Di Blasi; Massimo Santoro; Marcella Masciullo; Giulia Conte; Venanzio Valenza; Antonello Damiani; Giacomo Della Marca; Gabriella Silvestri
Journal:  Sleep Breath       Date:  2013-12-06       Impact factor: 2.816

7.  Hypoglossal nerve stimulation therapy does not alter tongue protrusion strength and fatigability in obstructive sleep apnea.

Authors:  Markus Wirth; Daniel Unterhuber; Franziska von Meyer; Benedikt Hofauer; Armin Ott; Guenther Edenharter; Danny J Eckert; Clemens Heiser
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

8.  Metabolic activity of the tongue in obstructive sleep apnea. A novel application of FDG positron emission tomography imaging.

Authors:  Andrew M Kim; Brendan T Keenan; Nicholas Jackson; Eugenia L Chan; Bethany Staley; Drew A Torigian; Abass Alavi; Richard J Schwab
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

Review 9.  Intermittent hypoxia, respiratory plasticity and sleep apnea in humans: present knowledge and future investigations.

Authors:  Jason H Mateika; Ziauddin Syed
Journal:  Respir Physiol Neurobiol       Date:  2013-04-12       Impact factor: 1.931

Review 10.  Adult obstructive sleep apnoea.

Authors:  Amy S Jordan; David G McSharry; Atul Malhotra
Journal:  Lancet       Date:  2013-08-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.